Connie A. Haley - Publications

Pretomanid dosing and pharmacokinetics in patients with TB in a high-resource setting.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: June 02, 2026

Curated Cases from the TB Expert Network: Unplugged!: Navigating Uncertainty in Treatment of a Child with Multidrug-Resistant Tuberculosis.

Journal: Journal of clinical tuberculosis and other mycobacterial diseases

Published: May 08, 2026

Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024.

Journal: Open forum infectious diseases

Published: October 01, 2025

Linezolid Dosing and Pharmacokinetics in North American Patients With Tuberculosis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 16, 2024

Analysis of panel physician inquiries to U.S. TB Centers of Excellence, 2018-2022.

Journal: IJTLD open

Published: April 10, 2024

NTCA Guidelines for Respiratory Isolation and Restrictions to Reduce Transmission of Pulmonary Tuberculosis in Community Settings.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 25, 2024

Use of Interferon-Gamma Release Assays in Children <2 Years Old.

Journal: Journal of the Pediatric Infectious Diseases Society

Published: March 19, 2023

Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 07, 2023

Pretomanid in the Treatment of Patients with Tuberculosis in the United States.

Journal: The New England journal of medicine

Published: September 02, 2022

Challenges in LTBI care in the United States identified using a nationwide TB medical consultation database.

Journal: Public health action

Published: April 07, 2021

Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013-2018.

Journal: Journal of clinical tuberculosis and other mycobacterial diseases

Published: December 18, 2020

Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.

Journal: Emerging infectious diseases

Published: November 23, 2020